Rogier Versteeg

dept. head

Amsterdam UMC, University of Amsterdam

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Cancer Biology Cancer Biology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (12)

Ali Rihani

Karolinska Institutet

SWEDEN

View details

Peter Sminia

Vrije Universiteit

NETHERLANDS

View details

Vincent de Boer

Assistant Professor

Wageningen University & Research

NETHERLANDS

View details

Sara Ek

SWEDEN

View details

Bart A Westerman

NETHERLANDS

View details

Wessel van Wieringen

University of Amsterdam

NETHERLANDS

View details

Brian Miller

Assistant Professor

University of North Carolina at Chapel Hill

UNITED STATES

View details

Johannes Hubertus Schulte

Head of Pediatric Stem Cell Transplantation; Professor of Pediatric Oncology Research

Charité Universitätsmedizin Berlin - Campus Virchow-Klinikum

GERMANY

View details

Giovanni Perini

University of Bologna

ITALY

View details

Giorgio Milazzo

Senior Assistant Professor in Genetics

University of Bologna

ITALY

View details

Malgorzata Krajewska

Lecturer, Principal Investigator

University College Cork

IRELAND

View details

Jayne Murray

Children's Cancer Institute Australia

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rogier Versteeg

Research Interests

Explore related searches

Contact this professor

Articles (10)

SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry.

FOXO3A-short is a novel regulator of non-oxidative glucose metabolism associated with human longevity.

MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma.

Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes.

A Common Genomic Denominator for Neuroblastoma and Differentiated Thyroid Carcinoma? A Case Series in Children.

DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma.

Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors.

A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma.

Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastoma.

A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities

Collaborators (12)

Ali Rihani

Peter Sminia

Vincent de Boer

Sara Ek

Bart A Westerman

Wessel van Wieringen

Brian Miller

Johannes Hubertus Schulte

Giovanni Perini

Giorgio Milazzo

Malgorzata Krajewska

Jayne Murray

Make your next move.